Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc.
7 Hills Pharma, LLC
Regeneron Pharmaceuticals
Alpha Tau Medical LTD.
Iovance Biotherapeutics, Inc.
Obsidian Therapeutics, Inc.
Filamon LTD
Ankyra Therapeutics, Inc
Replimune Inc.
Iovance Biotherapeutics, Inc.
Elephas
Elephas
OncoNano Medicine, Inc.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Massive Bio, Inc.
Nuvana Healthcare LTD
Medicenna Therapeutics, Inc.
HJN Sverige AB/Neko Health
HJN Sverige AB/Neko Health
Alpha Tau Medical LTD.
Mirai Medical
Apollo Medical Optics, Ltd
Iovance Biotherapeutics, Inc.
Alpha Tau Medical LTD.